((((((Howdy Dave))))))

In clinical trials, don't participants start on the lowest dose of the medication and titrate their way up on the drug? Aren't their blood levels measured along the way, before taking the med, after the first 2 weeks on a low dose, after every dose increase, etc.? That just seems logical to me, as a way of establishing a therapeutic level of the medication. If that is the case, then it would seem that they would have clinical data on lower doses achieving seizure control, if it occurred. That's why I felt it was implausible for that data to not exist.

Love & Light,

Rose